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The perfusion bioreactor system provides a 
temperature controlled and supportive environment 
with real-time viability assessment.
Figure 3: A schematic of the perfusion bioreactor.
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Shape of chamber: The shape of the chamber must 
allow medium to flow around the TheraCyte as to not 
limit oxygen transport into the device.
Temperature: Both the solubility of oxygen in the 
medium and the decay time of the fluorescent dye 
are affected by temperature variation. 
Oxygen diffusion: Oxygen exchange from the 
medium before it reaches the oxygen sensors has a 
large impact on the accuracy of the calibration. Also 
oxygen diffusion to or from the sensors can have a 
significant effect on measured OCR. 
Lower sensitivity to oxygen at high pO2: The oxygen 
sensors are less accurate and more unstable at high 
oxygen concentrations.
Flow rate and sensor position do not effect oxygen 
measurement
Results: Factors Influencing OCR Measurement
An empirical second order polynomial equation 
which describes the relationship between the pO2
and the fluorescent decay time (τ) was used to 
generate a calibration curve:
𝜏0
𝜏
= 1 + 𝐾1[𝑝𝑂2] + 𝐾2[𝑝𝑂2]
2
Equation 2:  The equation used to calibrate the oxygen sensors for 
use from 0 to 100 % O2. 𝜏0 is the decay time at 0% O2. 𝐾1 and 𝐾2
are constants.
Methods: To calibrate the system τ0, τ21, and τ100 were 
measured in medium bubbled with nitrogen, lab air, 
and oxygen respectively for each sensor. 
Three Point Calibration Curves:
Figure 4: An example of two calibration curves.
Results: A Three Point Calibration Procedure
Membrane oxygenator:
 An oxygenator in the circuit before the bioreactor 
would ensure an accurate calibration
 Membrane oxygenation instead of bubbling gas in 
medium will allow more temperature control
 Accurate control of the oxygen level in the medium 
will be required for future TheraCyte experiments.
Oxygen impermeable bioreactor:
 Building the bioreactor from an oxygen 
impermeable material will eliminate the effect of 
oxygen leakage on the measured pO2 difference.
Serializable: 
 A sterile system is required for longer 
experiments.
Gas calibration:
 To reduce the calibration time the possibility of a 
gas calibration should be considered. 
Recommendations for Future Designs:
 Islet transplantation is a promising treatment for 
type 1 diabetes, an autoimmune disease targeting 
the insulin producing cells of the pancreas.
The TheraCyte encapsulation device protects the 
transplanted islets (clusters of pancreas cells) from 
the immune system while allowing the cells access 
to nutrients and oxygen. 
Oxygen consumption rate (OCR) is an indicator of 
cell viability [1].
Figure 1: The TheraCyte Device for islet transplant.
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Contact Information:
1. Medium reservoir, high glucose 
DMEM
2. Temperature probe
3. Medium outlet
4. Gas flow into medium
5. Masterflex tubing
6. Peristaltic pump, Instech
7. Heat exchangers
8. Fiber-optic flow through oxygen 
probe, arterial
9. Bioreactor
10. TheraCyte
11. Fiber-optic flow through oxygen 
probe, venous
12. In-line temperature probe
13. Medium return
Methods: βTC-3 cells were cultured, encapsulated in a TheraCyte 
device, and the perfusion bioreactor system was used to measure 
the cellular OCR. The OCR of cells from the same passage was 
measured in a stirred micro-chamber system.
Cylindrical Chamber Bioreactor:
The OCR was measured to be 982 nmol/min·mgDNA
in the perfusion bioreactor which differed 
significantly from the micro-chamber measurement 
of 128 nmol/min·mgDNA. 
Possible reasons for the large over estimate of OCR 
include oxygen diffusion from the chamber between 
the probes,  error from the calibration due to oxygen 
exchange in the tubing, and possible contamination 
in the medium.
Figure 5: The cylindrical chamber bioreactor.
Flat Chamber Bioreactor:
Figure 6: The observed and predicted pO2 difference across the 
bioreactor. The predicted curve was calculated based on the mass 
balance equation (Eq. 1) and stirred micro-chamber OCR data.
The pO2 difference across the bioreactor decreased 
with flow rate, however it was not inversely 
proportional to the flowrate as predicted. 
The pO2 difference was similar when measured 
without the TheraCyte in the chamber suggesting 
very little consumption and oxygen diffusion from 
the chamber.
Figure 7: The flat chamber bioreactor.
Results: Comparison of Bioreactor Designs
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This project was focused on the development of a 
device to study the effect of various oxygen and 
glucose environments on the oxygen consumption rate 
of encapsulated islets in vitro. The device will be used 
to better understand the behavior and oxygen 
requirements of transplanted islets in vivo. 
1. Develop a 3-point calibration procedure 
which will enable accurate oxygen 
measurement from 0 to 760 mmHg.
2. Characterize the bioreactor system
• Compare two bioreactor designs
• Determine factors affecting measurement
• Identify requirements of the next design 
iteration
Objectives:
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Fiber optic oxygen sensors detect the partial 
pressure of oxygen (pO2) in the medium. The pO2 is 
measured at the inlet and outlet of the chamber. 
Figure 2: And oxygen sensor used to measure pO2.
Figure 3: The perfusion bioreactor system.
OCR is calculated using a mass balance equation 
adapted from whole organ OCR measurement [2]:
𝑂𝐶𝑅 =
𝑄 × 𝑝𝑂2,𝑖𝑛𝑙𝑒𝑡 − 𝑝𝑂2,𝑜𝑢𝑡𝑙𝑒𝑡 × 𝛼
𝑛
Equation 1: Mass balance equation for determining OCR 
(fmol/min/cell) from inlet and outlet pO2 (mmHg), flowrate (Q, 
mL/min), the solubility of oxygen in medium at 37°C (α=1.27 
nmol/mL·mmHg), and the number of encapsulated cells (n). 
The Perfusion Bioreactor System:
